MK-6240: Clinical Trials

4 trials of MK-6240, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 enrolling by invitation, 1 not yet recruiting, 1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Not yet recruiting 1
Phase 21Enrolling by invitation 1

Follow MK-6240: new trials by email Literature Review of MK-6240 trials Research Report on MK-6240

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau
Neuronavigation-guided single-element focused ultrasound transducer, Lumason, Magnetic Resonance Imaging (MRI) with or without gadolinium contrast agents - Alzheimer Disease, Early Onset
Phase 1Not yet recruitingColumbia University62027-08-012026-05-13
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
Biomarker Data Collection, MK6240 - Mild Cognitive Impairment, Alzheimer's Disease
RecruitingGAP Innovations, PBC12002024-09-262026-04-15
Alzheimer's Disease Neuroimaging Initiative 4
Neuraceq, Amyvid, Tauvid - Mild Cognitive Impairment, Alzheimer Disease
Enrolling by invitationUniversity of Southern California15002023-06-092026-09-29
Tau PET Imaging in the Northern Manhattan Study of Metabolism and Mind.
18F-MK6240 injection - Diabetes Mellitus, Type 2, Pre-diabetes
Phase 2Enrolling by invitationColumbia University6002018-07-242025-05-06

Conditions studied

Alzheimer Disease (3)  ·  Cognitive Dysfunction (2)  ·  Pick Disease of the Brain (2)  ·  Cognition Disorders (1)  ·  Dementia (1)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Glucose Intolerance (1)  ·  Hyperglycemia (1)  ·  Memory Disorders (1)  ·  Plaque, Amyloid (1)

Sponsors

Columbia University (2)  ·  GAP Innovations, PBC (1)  ·  University of Southern California (1)

Countries

United States (4)  ·  Canada (2)  ·  United Kingdom (1)

Top investigators

Grace McIlvain, PhD (1)  ·  Jose A. Luchsinger, MD (1)  ·  Michael Weiner, MD (1)  ·  Paul Aisen, MD (1)  ·  Ronald Petersen, MD, PHD (1)

Results publications

PMID 34057284

NIH funding

R01AG050440 (1), R01AG055299 (1), RF1AG051556 (1), U19AG024904 (1)